A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus

NCT06530849 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
118
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gracell Biotechnologies (Shanghai) Co., Ltd.

Collaborators